Inhibitors of HCV NS5A: From iminothiazolidinones to symmetrical stilbenes

ACS Medicinal Chemistry Letters

Volumn 2, Issue 3, 2011, Pages 224-229

  Romine, Jeffrey L ^a   St Laurent, Denis R ^a   Leet, John E ^a   Martin, Scott W ^a   Serrano Wu, Michael H ^a,c   Yang, Fukang ^a   Gao, Min ^b   O'Boyle, Donald R ^b   Lemm, Julie A ^b   Sun, Jin Hua ^b   Nower, Peter T ^b   Huang, Xiaohua ^a   Deshpande, Milind S ^a,d   Meanwell, Nicholas A ^a   Snyder, Lawrence B ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b B Ristol Myers Squibb Research and Development   (United States)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^d Achillion Pharmaceuticals   (United States)

Author keywords

HCV NS5A inhibitor; iminothiazolidinone; stilbene

Indexed keywords

ALANINE; BMS 790052; BMS 824; BMS 858; DIMETHYL SULFOXIDE; NONSTRUCTURAL PROTEIN 5A; PROLINE; STILBENE; THIAZOLE DERIVATIVE; THIOHYDANTOIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG POTENCY; FRACTIONATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; NONHUMAN; OXIDATION; PHARMACOPHORE; PRIORITY JOURNAL; REPLICON; STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 79952682354     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml1002647     Document Type: Article

References (32)

1. Kim, W. R. Global Epidemiology and Burden of Hepatitis C Microbes Infection 2002, 4, 1219-1225 (Pubitemid 35435276)
2. Hoofnagle, J. H.; Seeff, L. B. Peginterferon and Ribavirin for Chronic Hepatitis C N. Engl. J. Med. 2006, 355, 2444-2451 (Pubitemid 44903748)
3. Pearlman, B. L. Extended-Therapy Duration for Chronic Hepatitis C, Genotype 1: The Long and the Short of It World J. Gastroenterol. 2008, 14, 3621-3627
4. De Francesco, R.; Migliaccio, G. Challenges and Successes in Developing New Therapies for Hepatitis C Nature 2005, 436, 953-960 (Pubitemid 41191671)
5. Gao, M.; Nettles, R. E.; Belema, M.; Snyder, L. B.; Nguyen, V. N.; Fridell, R. A.; Serrano-Wu, M. H.; Langley, D. R.; Sun, J.-H.; O'Boyle, D. R.; Lemm, J. A.; Wang, C.; Knipe, J. O.; Chien, C.; Colonno, R. J.; Grasela, D. M.; Meanwell, N. A.; Hamann, L. G. Chemical Genetics Strategy Identifies an HCV NS5A Inhibitor with a Potent Clinical Effect Nature 2010, 465, 96-100
6. O'Boyle, D. R.; Nower, P. T.; Lemm, J. A.; Valera, L.; Sun, J.-H.; Rigat, K.; Colonno, R.; Gao, M. Development of a Cell-Based High-Throughput Specificity Screen Using a Hepatitis C Virus-Bovine Viral Diarrhea Virus Dual Replicon Assay Antimicrob. Agents Chemother. 2005, 49, 1346-1353 (Pubitemid 40463360)
7. Romine, J. L.; Martin, S. W.; Snyder, L. B.; Serrano-Wu, M.; Desphande, M. S.; Whitehouse, D. PCT WO 2004/014852 A2; 2007, US Patent 7,183,302 B2.
8. Erol, S.; Dogan, I. Axially Chiral 2-Arylimino-3-aryl-thiazolidine-4-one Derivatives: Enantiomeric Separation and Determination of Racemization Barriers by Chiral HPLC J. Org. Chem. 2007, 72, 2494-2500 (Pubitemid 46536180)
9. Garnaik, M. B. K.; Behera, R. Influence of Substituents on the Synthesis of Thiazolidinones. Indian J. Chem. 1987, 26B, 779 - 781.
10. St. Laurent, D. R.; Gao, Q.; Wu, D.; Serrano-Wu, M. H. Regioselective Synthesis of 3-(Heteroaryl)-iminothiazolindin-4-ones Tetrahedron Lett. 2004, 45, 1907-1910
11. 1 Receptor Agonists J. Med. Chem. 2010, 53, 4198-4211
12. Kumar, G.; Parasuraman, P.; Sharma, S. K.; Banerjee, T.; Karmodiya, K.; Surolia, N.; Surolia, A. Discovery of a Rhodanine Class of Compounds as Inhibitors of Plasmodium falciparum Enoyl-Acyl Carrier Protein Reductase J. Med. Chem. 2007, 50, 2665-2675 (Pubitemid 46896074)
13. The diastereomers at the C-5 position of 2 were separated by chiral prep HPLC but observed to rapidly equilibrate due to facile keto-enol tautomerism (see Supporting Information for LC trace).
14. Compounds 2 - 15 were prepared in library format using parallel synthesis methodology and subject to minimal purification. All compounds were of at least 70% purity, and MWs were confirmed by LCMS.
15. Lemm, J. A.; O'Boyle, D. R.; Liu, M.; Nower, P. T.; Colonno, R.; Deshpande, M. S.; Snyder, L. B.; Martin, S. W.; St. Laurent, D. R.; Serrano-Wu, M. H.; Romine, J. L.; Meanwell, N. A.; Gao, M. Identification of Hepatitis C Virus NS5A Inhibitors J. Virol. 2010, 84, 482-491
16. See Supporting Information for HPLC stability studies and experimental details. In DMSO, compounds 2 and 18 underwent complete conversion to 46 and 47, respectively. All compounds were dissolved and diluted in DMSO prior to evaluation in replicon and preincubation in media.
17. Lemm, J. A.; Leet, J. E.; O'Boyle, D. R., II; Romine, J. L.; Huang, X.; Schroeder, D. R.; Alberts, J.; Cantone, J. L.; Sun, J.-H.; Nower, P. T.; Martin, S. W.; Serrano-Wu, M. H.; Meanwell, N. A.; Snyder, L. B.; Gao, M. Discovery, Isolation and Synthesis of Potent Hepatitis C Virus NS5A Inhibitors with Dimeric Structures. Manuscript submitted.
18. Giese, B. Radicals in Organic Synthesis: Formation of Carbon-Carbon Bonds; Pergamon Press: New York, 1986.
19. Viehe, H. G.; Janousek, Z.; Merenyi, R.; Stella, L. The Captodative Effect Acc. Chem. Res. 1985, 18, 148-154
20. Schmidt, V. A.; Alexanian, E. J. Metal-Free, Aerobic Dioxygenation of Alkenes Using Hydroxamic Acids Angew. Chem., Int. Ed. 2010, 49, 4491-4494
21. Rowlands, G. J. Radicals in Organic Synthesis. Part 1 Terahedron 2009, 65, 8603-8655
22. Kates, S. A.; Dombroski, M. A.; Snider, B. B. Manganese(III)-Based Oxidative Free-Radical Cyclization of Unsaturated β-Keto Esters, 1,3-Diketones, and Malonate Diesters J. Org. Chem. 1990, 55, 2427-2436
23. Snider, B. B. Manganese(III)-Based Oxidative Free-Radical Cyclizations Chem. Rev. 1996, 96, 339-363 (Pubitemid 126637724)
24. Chemical shifts were consistent with the presence of an imine bond (not present in 51), while H-N long-range correlation indicated an amide nitrogen (see Supporting Information).
25. 50 = 2 nM. Dimer and acetates 52 and 53 were formed as single compounds with no evidence of diastereomers being formed (see Supporting Information).
26. For the radical dimerization process, see: Obata, N.; Niimura, K. Oxidative Dehydrodimerization of N -Acyl α-Amino-acids: Synthesis of Novel Di-αα′-amino-acid Derivatives Chem. Commun. 1977, 238-239
27. Thiohydantoins hydrolyze under these conditions to the thioureas if not isolated promptly.
28. Serrano-Wu, M.; Belema, M.; Snyder, L. B.; Meanwell, N. A.; St. Laurent, D. R.; Kakarl, R.; Nguyen, V. N.; Qui, Y.; Yang, X.; Leet, J. E.; Gao, M.; O'Boyle, D. R., II; Lemm, J. A.; Yang, F. US 2006/0276511 A1.
29. The alanine analogue of stilbene 55 proved to be too insoluble in DMSO to evaluate in the replicon assay.
30. Tellinghuisen, T. L.; Marcotrigiano, J.; Rice, C. M. Structure of the Zinc-Binding Domain of an Essential Component of the Hepatitis C Virus Replicase Nature 2005, 435, 374-379 (Pubitemid 40745549)
31. Love, R. A.; Brodsky, O.; Hickey, M. J.; Wells, P. A.; Cronin, C. N. Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus J. Virol. 2009, 83, 4395-4403
32. Schmitz, U.; Tan, S.-L. NS5A-From Obscurity to New Target for HCV Therapy Recent Pat. Anti-Infect. Drug Discov. 2008, 3, 77-92